Sernova Biotherapeutics

(OTC) SEOVF

Current Price$0.11

Market Cap$38.95M

Since IPO (2012)-52%

5 Year-91%

1 Year-6%

1 Month-5%

Sernova Biotherapeutics Financials at a Glance

Market Cap

$38.95M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$11.84M

EPS (TTM)

-$0.03

P/E Ratio

-4.39

Dividend

$0.00

Beta (Volatility)

0.41 (Low)

Dividend

$0.00

Beta (Volatility)

0.41 (Low)

Price

$0.11

Volume

418

Open

$0.11

Price

$0.11

Volume

418

Open

$0.11

Previous Close

$0.11

Daily Range

$0.11 - $0.11

52-Week Range

$0.09 - $0.16

Estimated Earnings Date

Sep 10, 2026

Dividend

$0.00

Beta (Volatility)

0.41 (Low)

Price

$0.11

Volume

418

Open

$0.11

Previous Close

$0.11

Daily Range

$0.11 - $0.11

52-Week Range

$0.09 - $0.16

Estimated Earnings Date

Sep 10, 2026

SEOVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sernova Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jonathan M. N. Rigby, MBA

Website

www.sernova.com

Headquarters

London, ON N6G 4X8, GB

SEOVF Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-8%

Earnings Yield

-22.78%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$38.95M

Shares Outstanding

347.73M

Volume

418

Avg. Volume

24.89K

Financials (TTM)

Gross Profit

-CA$342.54K

Operating Income

-CA$15.02M

EBITDA

-CA$14.66M

Operating Cash Flow

-CA$10.91M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$10.91M

Cash & ST Invst.

CA$264.97K

Total Debt

CA$17.28M

Sernova Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$4.43K

N/A

Gross Margin

0.00%

N/A

Market Cap

$38.95M

N/A

Market Cap/Employee

$2.29M

N/A

Employees

N/A

Net Income

-CA$3.23M

+14.6%

EBITDA

-CA$2.29M

+33.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

CA$1.05M

-47.3%

Total Debt

CA$2.45M

-48.2%

Accounts Receivable

CA$116.80K

-73.0%

Inventory

CA$0.00

N/A

Long Term Debt

CA$229.16K

-81.2%

Short Term Debt

CA$2.22M

-36.9%

Return on Assets

-7.71%

N/A

Return on Invested Capital

1.09%

N/A

Free Cash Flow

-CA$2.21M

+42.5%

Operating Cash Flow

-CA$2.21M

+42.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MDDVFMedical Developments International Limited

MDDVFMedical Developments International Limited$0.37+0.00%

PVCTProvectus Biopharmaceuticals, Inc.

PVCTProvectus Biopharmaceuticals, Inc.$0.06-10.29%

DTCFFDefence Therapeutics Inc.

DTCFFDefence Therapeutics Inc.$0.39+5.78%

MMIRFMedMira Inc.

MMIRFMedMira Inc.$0.01+0.00%

RLFTFMindMaze Therapeutics Holding S.A.

RLFTFMindMaze Therapeutics Holding S.A.$0.38+0.00%

DSOLDrug Free Solution, Inc.

DSOLDrug Free Solution, Inc.$0.00+0.00%

BBIXFBonus BioGroup Ltd.

BBIXFBonus BioGroup Ltd.$0.13+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$124.57+0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

ASTSAST SpaceMobile

ASTSAST SpaceMobile$82.41-0.16%

Questions About SEOVF

What is the current price of Sernova Biotherapeutics?

Sernova Biotherapeutics is trading at $0.11 per share.

What is the 52-week range for Sernova Biotherapeutics?

Over the past 52 weeks, Sernova Biotherapeutics has traded between $0.09 and $0.16.

How much debt does Sernova Biotherapeutics have?

As of the most recent reporting period, Sernova Biotherapeutics reported total debt of CA$1.80M.

How much cash does Sernova Biotherapeutics have on hand?

Sernova Biotherapeutics reported CA$773.75K in cash and cash equivalents in its most recent financial results.

What is Sernova Biotherapeutics’s dividend yield?

Sernova Biotherapeutics does not currently have a dividend yield.

Sernova Biotherapeutics

Sernova Biotherapeutics Financials at a Glance

SEOVF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sernova Biotherapeutics

SEOVF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sernova Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SEOVF

What is the current price of Sernova Biotherapeutics?

What is the 52-week range for Sernova Biotherapeutics?

How much debt does Sernova Biotherapeutics have?

How much cash does Sernova Biotherapeutics have on hand?

What is Sernova Biotherapeutics’s dividend yield?

Premium Investing Services